Company Overview of Thrombolytic Science International, LLC
Thrombolytic Science International, LLC engages in the development of a thrombolytic product. It provides M5, a thrombolytic drug that is used for percutaneous coronary intervention and ischemic stroke. The company was incorporated in 2004 and is based in Cambridge, Massachusetts.
763D Concord Avenue
Cambridge, MA 02138
Founded in 2004
Key Executives for Thrombolytic Science International, LLC
Similar Private Companies By Industry
|Molecular Logix, Inc.||United States|
|Bioplus Pharmaceuticals Inc.||United States|
|Visionary Therapeutics Corporation||United States|
|Viroxis Corporation||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Thrombolytic Science International, LLC, please visit www.tsillc.net. Company data is provided by Capital IQ. Please use this form to report any data issues.